What is a breakthrough?
For medical researchers, a breakthrough is that
“ah-ha!” moment – an answer to a question
that brings them one step closer to the goal of improving, extending and,
ultimately, saving lives.
This year, one such breakthrough came in a most unusual package: our canine
companions. Through American
Brain Tumor Association-funded research, dogs diagnosed with naturally-occurring
meningioma brain tumors – the most common brain tumor in dogs and humans – were
treated with a personal vaccine, designed to utilize the dog’s own tumor cells
to trigger its immune system. The data suggests that the vaccine is better than
either surgery alone, or surgery and radiation, and will hopefully lead to
human clinical trials.
another significant breakthrough, reported in the March 2011 issue of the
journal Nature Medicine as one of the “most relevant recent discoveries
in cancer research,” ABTA-supported research discovered a genetic mutation
associated with brain tumors, called IDH1. The mutation presents a springboard for new approaches to
diagnosis and treatment.
first national organization committed to funding brain tumor research, the ABTA
has funded generations of researchers, many of whom lead brain tumor programs
at some of the nation’s most prestigious institutions, influence research
trends and mentor the next generation of leaders.
brain tumor patients and caregivers, though, a breakthrough can also be
something far more immediate and personal – a calm, reassuring voice of an ABTA
Care Consultant on our CareLine; a welcome response to an email sent in the
middle of a restless night; vital information available online in a time of
desperate need. At every step, we assist patients and caregivers to make
breakthroughs in their understanding — helping to inform their choices in
treatment, care and recovery.
The ABTA is the only national organization that provides this invaluable
patient and caregiver support.
aren’t the end. Each one has opened pathways to new thinking, better
understanding and more effective treatments. Through your generous gift, the
American Brain Tumor Association will continue to lead the way in making
breakthroughs – both in labs and in lives.
We thank you for your generosity.